Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients

Chao Xia,Wei Huang,Yun-Liang Chen,Hai-Bin Fu,Ming Tang,Tao-Lan Zhang,Jing Li,Guo-Hua Lv,Yi-Guo Yan,Zhi-Hua Ouyang,Nvzhao Yao,Cheng Wang,Ming-Xiang Zou

DOI: https://doi.org/10.3389/fimmu.2023.1194064

IF: 7.3

2023-04-14

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.797407.].

immunology

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity

Hao Zheng,Wen-juan Zheng,Zhen-guang Wang,Yuan-ping Tao,Zhi-ping Huang,Le Yang,Liu Ouyang,Zhi-qing Duan,Yi-nuo Zhang,Bo-ning Chen,Dai-min Xiang,Gang Jin,Lu Fang,Fan Zhou,Bo Liang

DOI: https://doi.org/10.3389/fimmu.2022.1093403

IF: 7.3

2022-12-08

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.845193.].

immunology
Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Xinhua Chen,Huimin Zhang,Minghao Wang,Hao Liu,Yanfeng Hu,Tian Lin,Hao Chen,Mingli Zhao,Tao Chen,Guoxin Li,Jiang Yu,Liying Zhao

DOI: https://doi.org/10.3389/fimmu.2023.1235273

IF: 7.3

2023-06-15

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783695.].

immunology
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao,Yi Wang,Denglong Wu,Baoying Hu

DOI: https://doi.org/10.3389/fonc.2021.731942

IF: 4.7

2021-07-21

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.666418.].

oncology
Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.583084.].
Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer

Peijie Chen,Yuting Gao,Si Ouyang,Li Wei,Min Zhou,Hua You,Yao Wang

DOI: https://doi.org/10.3389/fphar.2021.723153

IF: 5.6

2021-08-25

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.585255.].

pharmacology & pharmacy
Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Yanan Wu,Meng Yuan,Chenlin Wang,Yanfei Chen,Yan Zhang,Jiandong Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1166352

IF: 7.3

2023-02-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1102778.].

immunology
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Zongxia Wang,Lizhou Jia,Yushu sun,Chunli Li,Lingli Zhang,Xiangcheng Wang,Hao Chen

DOI: https://doi.org/10.3389/fmolb.2021.727347

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.682594.].

biochemistry & molecular biology
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-03-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].

oncology
Corrigendum: High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia

Junlin Zhang,Liying Liu,Jinshuang Wei,Xiaojing Wu,Jianming Luo,Hongying Wei,Liao Ning,Yunyan He

DOI: https://doi.org/10.3389/fonc.2023.1212991

2023-08-21

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1068094.].
Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Sheng Liu,Wenting Tang,Jing Cao,Mei Shang,Sun Hengchang,Jiao Gong,Bo Hu

DOI: https://doi.org/10.3389/fgene.2024.1357409

IF: 3.7

2024-01-26

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.904114.].

genetics & heredity
Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Fang-Ze Wei,Shi-Wen Mei,Zhi-Jie Wang,Jia-Nan Chen,Hai-Yu Shen,Fu-Qiang Zhao,Juan Li,Zheng Liu,Qian Liu

DOI: https://doi.org/10.3389/fonc.2020.634122

IF: 4.7

2020-12-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.573295.].

oncology
Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC

Xiao Wang,Chao Liang,Xin Yao,Ruo-Han Yang,Zhan-Sheng Zhang,Fan-Ye Liu,Wen-Qi Li,Shu-Hua Pei,Jing Ma,Song-Qiang Xie,Dong Fang

DOI: https://doi.org/10.3389/fphar.2021.724799

IF: 5.6

2021-07-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.577108.].

pharmacology & pharmacy
Erratum: PD-L1 expression in colon cancer and its relationship with clinical prognosis.

Tao Shan,Shuo Chen,Tao Wu,Yi Yang,Shunle Li,Xi Chen

2022-01-01

Abstract:[This corrects the article on p. 1764 in vol. 12, PMID: 31933995.].
Corrigendum: H3K27M mutation doesn’t mean worse prognosis in old patients

Xiao Mu Hu,Xiao yu Nie,Kai lun Xu,Yin Wang,Feng Tang,Zun guo Du,Ji Xiong

DOI: https://doi.org/10.3389/fonc.2022.1061604

IF: 4.7

2023-01-12

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.912166.].

oncology
Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

Tao Hou,Shun Jiang,Yapeng Wang,Yangchun Xie,Haixia Zhang,Yeqian Feng,Fang Ma,Jin’an Ma,Xianling Liu,Chunhong Hu

DOI: https://doi.org/10.3389/fonc.2021.705406

IF: 4.7

2021-06-02

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.608300.].

oncology
Corrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study

Min Yuan,Zhongzheng Zhu,Wei Mao,Hui Wang,Hong Qian,Jianguo Wu,Xianling Guo,Qing Xu

DOI: https://doi.org/10.3389/fonc.2021.796625

IF: 4.7

2022-01-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.683502.].

oncology
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
Corrigendum: H3K27M mutation doesn't mean worse prognosis in old patients.

Xiao Mu Hu,Xiao Yu Nie,Kai Lun Xu,Yin Wang,Feng Tang,Zun Guo Du,Ji Xiong

DOI: https://doi.org/10.3389/fonc.2022.1061604

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.912166.].
Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Yun-Zhu Zeng,Yong-Qu Zhang,Jiong-Yu Chen,Li-Ying Zhang,Wen-Liang Gao,Xue-Qiong Lin,Shao-Min Huang,Fan Zhang,Xiao-Long Wei

DOI: https://doi.org/10.3389/fonc.2021.767805

IF: 4.7

2021-10-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.627713.].

oncology

Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity

Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Corrigendum: High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia

Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Corrigendum: PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC

Erratum: PD-L1 expression in colon cancer and its relationship with clinical prognosis.

Corrigendum: H3K27M mutation doesn’t mean worse prognosis in old patients

Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

Corrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Corrigendum: H3K27M mutation doesn't mean worse prognosis in old patients.

Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma